REQUEST A DEMO
Total
USD $0.00
Search more companies

Ibsa Pharma S.R.O. (Czech Republic)

Main Activities: Wholesale Trade | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Corporate, Subsidiary, and Regional Managing Offices
Full name: Ibsa Pharma S.R.O. Profile Updated: October 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Ibsa Pharma S.R.O. is an enterprise in Czech Republic, with the main office in Prague. The company operates in the Wholesale Trade sector. It was incorporated on April 19, 1995. Ibsa Pharma S.R.O. currently employs 50 - 99 (2026) people. The latest financial highlights indicate a net sales revenue increase of 13.43% in 2025. Its’ total assets recorded a negative growth of 28%. The enterprise’s net profit margin decreased by 0.05% in 2025.

Headquarters
Senovazne namesti 1463/5
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Ibsa Pharma S.R.O. report to view the information.

Website: http://www.ibi.cz

Basic Information
Total Employees:
Purchase the Ibsa Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Ibsa Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Ibsa Pharma S.R.O. report to view the information.
Incorporation Date:
April 19, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ibsa Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
13.43%▲
Total Operating Revenue
15.28%▲
Operating Profit
10.74%▲
EBITDA
2.21%▲
Net Profit/Loss for the Period
10.33%▲
Total Assets
-28%▼
Total Equity
6.37%▲
Operating Profit Margin
-0.07%▼
Net Profit Margin
-0.05%▼
Return on Equity (ROE)
0.21%▲
Quick Ratio
0.96%▲
Cash Ratio
0.49%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?